NAGIOS: RODERIC FUNCIONANDO

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

dc.contributor.author	Schernthaner, G.	es_ES
dc.contributor.author	Barnett, A. H.	es_ES
dc.contributor.author	Betteridge, D. J.	es_ES
dc.contributor.author	Carmena Rodríguez, Rafael	es_ES
dc.contributor.author	Ceriello, A.	es_ES
dc.contributor.author	Charbonnel, B.	es_ES
dc.contributor.author	Hanefeld, M.	es_ES
dc.contributor.author	Lehmann, R.	es_ES
dc.contributor.author	Malecki, M. T.	es_ES
dc.contributor.author	Nesto, R.	es_ES
dc.contributor.author	Pirags, V.	es_ES
dc.contributor.author	Scheen, A.	es_ES
dc.contributor.author	Seufert, J.	es_ES
dc.contributor.author	Sjohölm, A.	es_ES
dc.contributor.author	Tsatsoulis, A.	es_ES
dc.contributor.author	DeFronzo, R.	es_ES
dc.date.accessioned	2015-06-29T10:32:25Z
dc.date.available	2015-06-29T10:32:25Z
dc.date.issued	2010	es_ES
dc.identifier.citation	Diabetologia Vol. 53 Issue 7: pp. 1258-1269	es_ES
dc.identifier.uri	http://hdl.handle.net/10550/44785
dc.description.abstract	The ADA and the EASD recently published a consensus statement for the medical management of hyperglycaemia in patients with type 2 diabetes. The authors advocate initial treatment with metformin monotherapy and lifestyle modification, followed by addition of basal insulin or a sulfonylurea if glycaemic goals are not met (tier 1 recommendations). All other glucose-lowering therapies are relegated to a secondary (tier 2) status and only recommended for selected clinical settings. In our view, this algorithm does not offer physicians and patients the appropriate selection of options to individualise and optimise care with a view to sustained control of blood glucose and reduction both of diabetes complications and cardiovascular risk. This paper critically assesses the basis of the ADA/EASD algorithm and the resulting tiers of treatment options.	es_ES
dc.subject	ADA Consensus Statement	es_ES
dc.subject	Algorithm	es_ES
dc.subject	Cardiovascular risk	es_ES
dc.subject	EASD consensus statement	es_ES
dc.subject	Glucose-lowering therapy	es_ES
dc.subject	Hyperglycaemia	es_ES
dc.subject	Type 2 diabetes	es_ES
dc.title	Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis	es_ES
dc.type	journal article	es_ES
dc.identifier.doi	10.1007/s00125-010-1702-3	es_ES
dc.identifier.idgrec	057735	es_ES